superscript iic dna synthesis kit (Thermo Fisher)
99
Structured Review
Thermo Fisher
superscript iic dna synthesis kit
Superscript Iic Dna Synthesis Kit, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/superscript+iic+dna+synthesis+kit/Deoxyribonucleic+acid/us12474337-825-42-47
Average 99 stars, based on 1 article reviews
Superscript Iic Dna Synthesis Kit, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/superscript+iic+dna+synthesis+kit/Deoxyribonucleic+acid/us12474337-825-42-47
Average 99 stars, based on 1 article reviews
superscript iic dna synthesis kit - by Bioz Stars,
2026-10
99/100 stars
Images
Related Articles
Reverse Transcription Polymerase Chain Reaction:Article Title: Therapeutic agent for autoimmune diseases or allergy, and method for screening for the therapeutic agent Article Snippet: .. RT-PCR For RT-PCR analysis, RNA was isolated from immature bone marrow-derived dendritic cells, mature dendritic cells (CD40; 1 μg/ml, TNFa; 50 ng/ml), SVEC4-10 and HMVEC-dLy using RNeasykits (Qiagen), and treated with DNaseI (Invitrogen) to remove genome DNA. cDNAs was synthesized using a Article Title: Therapeutic agent for autoimmune diseases or allergy, and method for screening for the therapeutic agent Article Snippet: .. RT-PCR For RT-PCR analysis, RNA was isolated from immature bone marrow-derived dendritic cells, mature dendritic cells (CD40; 1 μg/ml, TNFα; 50 ng/ml), SVEC4-10 and HMVEC-dLy using RNeasykits (Qiagen), and treated with DNaseI (Invitrogen) to remove genome DNA. cDNAs was synthesized using a Article Title: Therapeutic agent for autoimmune diseases or allergy, and method for screening for the therapeutic agent Article Snippet: .. For RT-PCR analysis, RNA was isolated from spleens with RNeasykits (Qiagen) and treated with DNaseI (Invitrogen), and the genome DNA was removed. cDNAs was synthesized with a Article Title: Therapeutic agent for autoimmune diseases or allergy, and method for screening for the therapeutic agent Article Snippet: .. For RT-PCR analysis, RNA was isolated from spleens with RNeasykits (Qiagen) and treated with DNaseI (Invitrogen), and the genome DNA was removed. cDNAs was synthesized with a Isolation:Article Title: Therapeutic agent for autoimmune diseases or allergy, and method for screening for the therapeutic agent Article Snippet: .. RT-PCR For RT-PCR analysis, RNA was isolated from immature bone marrow-derived dendritic cells, mature dendritic cells (CD40; 1 μg/ml, TNFa; 50 ng/ml), SVEC4-10 and HMVEC-dLy using RNeasykits (Qiagen), and treated with DNaseI (Invitrogen) to remove genome DNA. cDNAs was synthesized using a Article Title: Therapeutic agent for autoimmune diseases or allergy, and method for screening for the therapeutic agent Article Snippet: .. RT-PCR For RT-PCR analysis, RNA was isolated from immature bone marrow-derived dendritic cells, mature dendritic cells (CD40; 1 μg/ml, TNFα; 50 ng/ml), SVEC4-10 and HMVEC-dLy using RNeasykits (Qiagen), and treated with DNaseI (Invitrogen) to remove genome DNA. cDNAs was synthesized using a Article Title: Therapeutic agent for autoimmune diseases or allergy, and method for screening for the therapeutic agent Article Snippet: .. For RT-PCR analysis, RNA was isolated from spleens with RNeasykits (Qiagen) and treated with DNaseI (Invitrogen), and the genome DNA was removed. cDNAs was synthesized with a Article Title: Therapeutic agent for autoimmune diseases or allergy, and method for screening for the therapeutic agent Article Snippet: .. For RT-PCR analysis, RNA was isolated from spleens with RNeasykits (Qiagen) and treated with DNaseI (Invitrogen), and the genome DNA was removed. cDNAs was synthesized with a Synthesized:Article Title: Therapeutic agent for autoimmune diseases or allergy, and method for screening for the therapeutic agent Article Snippet: .. RT-PCR For RT-PCR analysis, RNA was isolated from immature bone marrow-derived dendritic cells, mature dendritic cells (CD40; 1 μg/ml, TNFa; 50 ng/ml), SVEC4-10 and HMVEC-dLy using RNeasykits (Qiagen), and treated with DNaseI (Invitrogen) to remove genome DNA. cDNAs was synthesized using a Article Title: Therapeutic agent for autoimmune diseases or allergy, and method for screening for the therapeutic agent Article Snippet: .. RT-PCR For RT-PCR analysis, RNA was isolated from immature bone marrow-derived dendritic cells, mature dendritic cells (CD40; 1 μg/ml, TNFα; 50 ng/ml), SVEC4-10 and HMVEC-dLy using RNeasykits (Qiagen), and treated with DNaseI (Invitrogen) to remove genome DNA. cDNAs was synthesized using a Article Title: Therapeutic agent for autoimmune diseases or allergy, and method for screening for the therapeutic agent Article Snippet: .. For RT-PCR analysis, RNA was isolated from spleens with RNeasykits (Qiagen) and treated with DNaseI (Invitrogen), and the genome DNA was removed. cDNAs was synthesized with a Article Title: Therapeutic agent for autoimmune diseases or allergy, and method for screening for the therapeutic agent Article Snippet: .. For RT-PCR analysis, RNA was isolated from spleens with RNeasykits (Qiagen) and treated with DNaseI (Invitrogen), and the genome DNA was removed. cDNAs was synthesized with a DNA Synthesis:Article Title: Therapeutic agent for autoimmune diseases or allergy, and method for screening for the therapeutic agent Article Snippet: .. RT-PCR For RT-PCR analysis, RNA was isolated from immature bone marrow-derived dendritic cells, mature dendritic cells (CD40; 1 μg/ml, TNFa; 50 ng/ml), SVEC4-10 and HMVEC-dLy using RNeasykits (Qiagen), and treated with DNaseI (Invitrogen) to remove genome DNA. cDNAs was synthesized using a Article Title: Therapeutic agent for autoimmune diseases or allergy, and method for screening for the therapeutic agent Article Snippet: .. RT-PCR For RT-PCR analysis, RNA was isolated from immature bone marrow-derived dendritic cells, mature dendritic cells (CD40; 1 μg/ml, TNFα; 50 ng/ml), SVEC4-10 and HMVEC-dLy using RNeasykits (Qiagen), and treated with DNaseI (Invitrogen) to remove genome DNA. cDNAs was synthesized using a Article Title: Therapeutic agent for autoimmune diseases or allergy, and method for screening for the therapeutic agent Article Snippet: .. For RT-PCR analysis, RNA was isolated from spleens with RNeasykits (Qiagen) and treated with DNaseI (Invitrogen), and the genome DNA was removed. cDNAs was synthesized with a Article Title: Therapeutic agent for autoimmune diseases or allergy, and method for screening for the therapeutic agent Article Snippet: .. For RT-PCR analysis, RNA was isolated from spleens with RNeasykits (Qiagen) and treated with DNaseI (Invitrogen), and the genome DNA was removed. cDNAs was synthesized with a |